45 results
20-F/A
2023 FY
BLRX
Bioline Rx Ltd
26 Mar 24
Annual report (foreign) (amended)
4:57pm
positions in the global R&D division at Teva Pharmaceutical Industries Ltd. In her most recent position as Senior Director and Global Project Leader, Dr … of Ecogen Inc. and has held a variety of other positions, including manager of R&D and chief of immunochemistry at the International Genetic Science
6-K
EX-99
BLRX
Bioline Rx Ltd
23 Jun 23
Notice of Annual General Meeting of Shareholders
4:16pm
Inc. and has held a variety of other positions, including manager of R&D and chief of immunochemistry at the International Genetic Science
6-K
EX-99
BLRX
Bioline Rx Ltd
28 Jun 22
BioLineRx Announces Collaboration Agreement with GenFleet Therapeutics to Further Develop Motixafortide in
7:14am
proprietary R&D platform based on a deep understanding of disease biology and translational medicine, as well as on research into the latest
6-K
EX-99
BLRX
Bioline Rx Ltd
27 May 22
2022 Annual General Meeting of Shareholders
4:30pm
Director of Ecogen Inc. and has held a variety of other positions, including manager of R&D and chief of immunochemistry at the International Genetic
6-K
EX-99
jp4ku4sgv0whkc
27 Oct 21
2021 Annual General Meeting of Shareholders
5:05pm
6-K
EX-99
u05sp9muwacs687t r7f
19 Aug 20
2020 Annual General Meeting of Shareholders
4:34pm
6-K
EX-1
ziyi6bv6wvm29b
28 May 19
Current report (foreign)
7:04am
6-K
EX-99.1
adtals2
4 Feb 19
Current report (foreign)
4:30pm
20-F/A
EX-4.39
97vq6mo
22 Sep 15
Annual report (foreign) (amended)
12:00am
20-F/A
dilp77iya75wvw
23 Mar 15
Annual report (foreign) (amended)
12:00am